Jazz Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.About JAZZ
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio.
JAZZ Key Statistics
Stock Snapshot
Jazz Pharmaceuticals(JAZZ) stock is priced at $235.67, giving the company a market capitalization of 15.29B. It carries a P/E multiple of 16.25.
On 2026-10-04, Jazz Pharmaceuticals(JAZZ) stock traded between a low of $231.70 and a high of $237.77. Shares are currently priced at $235.67, which is +1.7% above the low and -0.9% below the high.
Jazz Pharmaceuticals(JAZZ) shares are trading with a volume of 537.16K, against a daily average of 739.96K.
During the past year, Jazz Pharmaceuticals(JAZZ) stock moved between $128.80 at its lowest and $266.38 at its peak.
During the past year, Jazz Pharmaceuticals(JAZZ) stock moved between $128.80 at its lowest and $266.38 at its peak.
JAZZ News
...
Jazz Pharmaceuticals (JAZZ) announced an update on their ongoing clinical study. Jazz Pharmaceuticals is launching a new real-world study on zanidatamab in adv...
Citi initiated coverage of Jazz Pharmaceuticals (JAZZ) with a Buy rating and $325 price target The firm believes the company’s oncology “transformation” is unde...
Analyst ratings
88%
of 24 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.